675 related articles for article (PubMed ID: 32599813)
1. COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment.
Arastehfar A; Carvalho A; van de Veerdonk FL; Jenks JD; Koehler P; Krause R; Cornely OA; S Perlin D; Lass-Flörl C; Hoenigl M
J Fungi (Basel); 2020 Jun; 6(2):. PubMed ID: 32599813
[TBL] [Abstract][Full Text] [Related]
2. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
[TBL] [Abstract][Full Text] [Related]
3. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
4. Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus.
Steenwyk JL; Mead ME; de Castro PA; Valero C; Damasio A; Dos Santos RAC; Labella AL; Li Y; Knowles SL; Raja HA; Oberlies NH; Zhou X; Cornely OA; Fuchs F; Koehler P; Goldman GH; Rokas A
Microbiol Spectr; 2021 Sep; 9(1):e0001021. PubMed ID: 34106569
[TBL] [Abstract][Full Text] [Related]
5. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
6. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.
Erami M; Hashemi SJ; Raiesi O; Fattahi M; Getso MI; Momen-Heravi M; Daie Ghazvini R; Khodavaisy S; Parviz S; Mehri N; Babaei M
Infection; 2023 Feb; 51(1):223-230. PubMed ID: 36107379
[TBL] [Abstract][Full Text] [Related]
8. Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience.
Serin I; Baltali S; Cinli TA; Goze H; Demir B; Yokus O
BMC Infect Dis; 2022 Nov; 22(1):822. PubMed ID: 36348480
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
[TBL] [Abstract][Full Text] [Related]
10. Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis - CAPA.
Cocio TA; Siqueira LPM; Riciluca KCT; Gimenes VMF; de Andrade TS; Benard G; Martínez R; Bollela VR
Braz J Infect Dis; 2023; 27(4):102793. PubMed ID: 37507102
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a
Giacobbe DR; Prattes J; Wauters J; Dettori S; Signori A; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Klimko N; Shadrivova O; Cornely OA; Rautemaa-Richardson R; Koehler P; Lagrou K; Bassetti M; Hoenigl M;
J Clin Microbiol; 2022 Apr; 60(4):e0229821. PubMed ID: 35321555
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
[TBL] [Abstract][Full Text] [Related]
13. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
[TBL] [Abstract][Full Text] [Related]
14. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility.
Lackner N; Thomé C; Öfner D; Joannidis M; Mayerhöfer T; Arora R; Samardzic E; Posch W; Breitkopf R; Lass-Flörl C
J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205848
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.
Hernández-Silva G; Corzo-León DE; Becerril-Vargas E; Peralta-Prado AB; Odalis RG; Morales-Villarreal F; Ríos-Ayala MA; Alonso TG; Agustín FD; Ramón AF; Hugo AV
Mycoses; 2024 Jan; 67(1):e13693. PubMed ID: 38214372
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.
Jiang Z; Chen S; Zhu Q; Xiao Y; Qu J
J Infect Public Health; 2022 Feb; 15(2):222-227. PubMed ID: 35032951
[TBL] [Abstract][Full Text] [Related]
18. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study.
Feys S; Vanmassenhove S; Kraisin S; Yu K; Jacobs C; Boeckx B; Cambier S; Cunha C; Debaveye Y; Gonçalves SM; Hermans G; Humblet-Baron S; Jansen S; Lagrou K; Meersseman P; Neyts J; Peetermans M; Rocha-Pereira J; Schepers R; Spalart V; Starick MR; Thevissen K; Van Brussel T; Van Buyten T; Van Mol P; Vandenbriele C; Vanderbeke L; Wauters E; Wilmer A; Van Weyenbergh J; Van De Veerdonk FL; Carvalho A; Proost P; Martinod K; Lambrechts D; Wauters J
Lancet Microbe; 2024 Mar; 5(3):e247-e260. PubMed ID: 38280387
[TBL] [Abstract][Full Text] [Related]
19. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.
Verweij PE; Rijnders BJA; Brüggemann RJM; Azoulay E; Bassetti M; Blot S; Calandra T; Clancy CJ; Cornely OA; Chiller T; Depuydt P; Giacobbe DR; Janssen NAF; Kullberg BJ; Lagrou K; Lass-Flörl C; Lewis RE; Liu PW; Lortholary O; Maertens J; Martin-Loeches I; Nguyen MH; Patterson TF; Rogers TR; Schouten JA; Spriet I; Vanderbeke L; Wauters J; van de Veerdonk FL
Intensive Care Med; 2020 Aug; 46(8):1524-1535. PubMed ID: 32572532
[TBL] [Abstract][Full Text] [Related]
20. A Tale of Two Hospitals: Comparing CAPA Infections in Two ICUs During the Spanish Fourth Pandemic Wave.
Sánchez-Castellano MÁ; Marcelo C; Marco J; Figueira-Iglesias JC; García-Rodríguez J
Mycopathologia; 2023 Aug; 188(4):335-344. PubMed ID: 37256502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
